antibody

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

Trial Design and Participants VRC 614 was a phase 1, open-label, dose-escalation clinical trial. The primary objectives of the trial were to evaluate the safety and side-effect profile of L9LS administered at intravenous doses of 1, 5, and 20 mg per kilogram of body weight and at a subcutaneous dose of 5 mg per kilogram. …

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria Read More »

Can you judge your COVID immunity with an antibody test? Israeli research says yes

Can you judge your COVID immunity with an antibody test? Israeli research says yes

Throughout the coronavirus pandemic, scientists have been reticent about using results of standard antibody tests to judge COVID immunity levels. But new Israeli research suggests such tests can be a reliable indicator. The scientists behind the study say such tests could be used as a screening tool for allocation of the first batches of updated vaccines, …

Can you judge your COVID immunity with an antibody test? Israeli research says yes Read More »